AU2002340465A1 - Cyclo(prolyl-glycine) and methods of use to treat neural disorders - Google Patents

Cyclo(prolyl-glycine) and methods of use to treat neural disorders

Info

Publication number
AU2002340465A1
AU2002340465A1 AU2002340465A AU2002340465A AU2002340465A1 AU 2002340465 A1 AU2002340465 A1 AU 2002340465A1 AU 2002340465 A AU2002340465 A AU 2002340465A AU 2002340465 A AU2002340465 A AU 2002340465A AU 2002340465 A1 AU2002340465 A1 AU 2002340465A1
Authority
AU
Australia
Prior art keywords
prolyl
cyclo
glycine
methods
neural disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002340465A
Inventor
Peter David Gluckman
Jian Guan
Frank Sieg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neuronz Ltd
NEURONZ BIOSCIENCES Inc
Original Assignee
Neuronz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neuronz Ltd filed Critical Neuronz Ltd
Publication of AU2002340465A1 publication Critical patent/AU2002340465A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AU2002340465A 2001-11-09 2002-11-12 Cyclo(prolyl-glycine) and methods of use to treat neural disorders Abandoned AU2002340465A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
NZ515371 2001-11-09
NZ51537101 2001-11-09
NZ51543201 2001-11-13
NZ515432 2001-11-13
NZ51555101 2001-11-16
NZ515551 2001-11-16
PCT/US2002/036235 WO2003039487A2 (en) 2001-11-09 2002-11-12 Cyclo(prolyl-glycine) and methods of use to treat neural disorders

Publications (1)

Publication Number Publication Date
AU2002340465A1 true AU2002340465A1 (en) 2003-05-19

Family

ID=27353943

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002340465A Abandoned AU2002340465A1 (en) 2001-11-09 2002-11-12 Cyclo(prolyl-glycine) and methods of use to treat neural disorders

Country Status (2)

Country Link
AU (1) AU2002340465A1 (en)
WO (1) WO2003039487A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7232798B2 (en) 2001-11-13 2007-06-19 Tran Loi H Neuroprotection and neuroegenisis by administering cyclic prolyl glycine
US8791117B2 (en) * 2003-09-03 2014-07-29 Neuren Pharmaceuticals Limited Cyclic glycyl-2-allyl proline improves cognitive performance in impaired animals
JP4842817B2 (en) * 2003-09-03 2011-12-21 ニューレン ファーマシューティカルズ リミテッド Neuroprotective bicyclic compounds and methods of use thereof
US20110319463A1 (en) * 2009-03-10 2011-12-29 Saten Pharamaceuticals Co., Ltd. Preventive or therapeutic agents for optic nerve disorders comprising 4,6-dichloro-1h-indole-2-carboxylic acid derivatives or salts thereof as active ingredients
WO2011037644A1 (en) * 2009-09-25 2011-03-31 Neuren Pharmaceuticals Limited Cyclic glycyl-2-allyl proline and its use in treatment of peripheral neuropathy
CN105902999A (en) * 2016-02-01 2016-08-31 四川好医生攀西药业有限责任公司 Pharmaceutical composition for treating peptic ulcer and its preparation method and use
CN105879005A (en) * 2016-02-01 2016-08-24 四川好医生攀西药业有限责任公司 Pharmaceutical composition for treating ulcerative colitis as well as preparation method and application of pharmaceutical composition
CN105879006A (en) * 2016-02-01 2016-08-24 四川好医生攀西药业有限责任公司 Pharmaceutical composition for treating diabetic foot ulcer as well as preparation method and application of pharmaceutical composition
EP3675890A4 (en) * 2017-08-28 2021-11-03 Vitality Wellness (NZ) Limited Improvements in igf-1 analysis, adjustment and disease management of non-neurological and/or neurological conditions
AU2019271189A1 (en) 2018-05-15 2021-01-07 Lloyd Hung Loi TRAN Therapeutic agent composition and method of use, for treatment of mild cognitive impairment, depression, and psychological disorders
JP6598412B1 (en) * 2019-06-04 2019-10-30 ゼライス株式会社 Food for improving cognitive function
WO2023113623A1 (en) * 2021-12-17 2023-06-22 The Cgp Lab Limited Animal, fungal and marine sources of cgp and increased cgp concentration for disease management and for treatment of non-neurological and/or neurological conditions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU757907B2 (en) * 1998-09-03 2003-03-13 Neuren Pharmaceuticals Limited Neuroprotection

Also Published As

Publication number Publication date
WO2003039487A2 (en) 2003-05-15
WO2003039487A3 (en) 2004-01-15

Similar Documents

Publication Publication Date Title
AU2002360195A1 (en) Phototherapy for psoriasis and other skin disorders
AU2003286567A1 (en) Methods for the treatment of skin disorders
AU2002332430A1 (en) Methods of treating neuropilin-mediated diseases
AU2003290548A1 (en) Prevention and treatment of synucleinopathic disease
AU2003239568A1 (en) Pyrrolotriazinone compounds and their use to treat diseases
AU2003239474A1 (en) Device and method for the treatment of cardiac disorders
AU2002257936A1 (en) Methods of well treatment
AU2003291342A1 (en) Benzotriazoles and methods of prophylaxis or treatment of metabolic-related disorders thereof
AU2002361811A1 (en) 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders
AU2002340465A1 (en) Cyclo(prolyl-glycine) and methods of use to treat neural disorders
EP1416957A4 (en) Treatment of immune disorders and b cell disorders
AU2001271887A1 (en) Methods for diagnosis and treatment of psychiatric disorders
AU2002360555A1 (en) Treatment of genitourinary tract disorders
AU2001278981A1 (en) Prevention and treatment of sexual arousal disorders
AU2003270536A1 (en) Method of treating skin disorders
AU2002362115A1 (en) Composition and methods for treatment of neurological disorders
AU2003272728A1 (en) Methods and compositions for treatment of neurological disorder
AU2002365936A1 (en) Compositions and methods to treat gastrointestinal disorders
AU7106300A (en) Treatment of skin disorders
AU2001251306A1 (en) Treatment of sleep disorders with hypocretin-1
AU2003213898A1 (en) Prevention and treatment of mycoplasma-associated diseases
AU2003270540A1 (en) Treatment of cyclooxygenase-3 mediated diseases and disorders
EP1539100A4 (en) Composition and methods for the treatment of skin disorders
AU2003301346A1 (en) Method of treating neurological diseases and disorders
AU2001267165A1 (en) Prevention and treatment of mycoplasma-associated diseases

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase